Literature DB >> 15357009

Wild ginseng prevents the onset of high-fat diet induced hyperglycemia and obesity in ICR mice.

Se Na Yun1, Sang Jung Moon, Sung Kwon Ko, Byung Ok Im, Sung Hyun Chung.   

Abstract

Ginseng is a shade-loving perennial herb that is cultivated mainly in Korea, Japan, and China. The ginseng root has been used as a tonic remedy, and its antidiabetic activity has been demonstrated as early as 1920s. Although wild ginseng was anecdotally thought to be superior to cultivated ginseng as far as pharmacological properties were concerned, there have been no prior reports on the antidiabetic effect of wild ginseng. In this study, we investigated the preventative anti-diabetic and anti-obese effects of wild ginseng ethanol extract (WGEE). In the preventive experiment, WGEE co-administered with a high fat diet significantly inhibited body weight gain, fasting blood glucose, triglyceride, and free fatty acid levels in a dose dependent manner. WGEE-treated mice at doses of 250 and 500 mg/kg improved the insulin resistance index by 55% and 61% compared to the high fat diet (HFD) control, respectively. Diameters of white and brown adipocytes were also decreased by 62% and 46% in the WG500-treated group compared to those in HFD fed control mice. Taken together, WGEE has potential as a preventive agent for type 2 diabetes mellitus (and possibly obesity) and deserves clinical trial in the near future.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15357009     DOI: 10.1007/bf02980150

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  43 in total

1.  Regulation of carbohydrate metabolism by indole-3-carbinol and its metabolite 3,3'-diindolylmethane in high-fat diet-induced C57BL/6J mice.

Authors:  Jayakumar Poornima; Sankaran Mirunalini
Journal:  Mol Cell Biochem       Date:  2013-09-27       Impact factor: 3.396

Review 2.  Natural products: a safest approach for obesity.

Authors:  Neeru Vasudeva; Neerja Yadav; Surendra Kumar Sharma
Journal:  Chin J Integr Med       Date:  2012-07-22       Impact factor: 1.978

Review 3.  Anti-obesogenic and antidiabetic effects of plants and mushrooms.

Authors:  Jan Martel; David M Ojcius; Chih-Jung Chang; Chuan-Sheng Lin; Chia-Chen Lu; Yun-Fei Ko; Shun-Fu Tseng; Hsin-Chih Lai; John D Young
Journal:  Nat Rev Endocrinol       Date:  2016-09-16       Impact factor: 43.330

4.  Anti-obesity effects of Chang-Chul-Eui-Ee-In-Tang [see text] in female rats with diet-induced obesity.

Authors:  Sunmin Park; Jung Bok Lee; James W Daily
Journal:  Chin J Integr Med       Date:  2011-12-03       Impact factor: 1.978

5.  Effects of Korean white ginseng extracts on obesity in high-fat diet-induced obese mice.

Authors:  Young-Sil Lee; Byung-Yoon Cha; Kohji Yamaguchi; Sun-Sil Choi; Takayuki Yonezawa; Toshiaki Teruya; Kazuo Nagai; Je-Tae Woo
Journal:  Cytotechnology       Date:  2010-09-23       Impact factor: 2.058

6.  Ginsenoside Rb1 increases insulin sensitivity through suppressing 11β-hydroxysteroid dehydrogenase type I.

Authors:  Bing Song; Li Ding; Haoqiang Zhang; Yafen Chu; Zhaohui Chang; Yali Yu; Dandan Guo; Shuping Zhang; Xuezheng Liu
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

Review 7.  A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity.

Authors:  Shirin Hasani-Ranjbar; Neda Nayebi; Bagher Larijani; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

Review 8.  Traditional chinese medicine in treatment of metabolic syndrome.

Authors:  Jun Yin; Hanjie Zhang; Jianping Ye
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-06       Impact factor: 2.895

9.  EFFECTS OF GINSENG AND ITS FOUR PURIFED GINSENOSIDES (Rb2, Re, Rg1, Rd) ON HUMAN PANCREATIC ISLET β CELL IN VITRO.

Authors:  John Z Q Luo; Joseph W Kim; LuGuang Luo
Journal:  Eur J Pharm Med Res       Date:  2016-01

10.  Ginseng on hyperglycemia: effects and mechanisms.

Authors:  John Zeqi Luo; Luguang Luo
Journal:  Evid Based Complement Alternat Med       Date:  2008-01-03       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.